Global Hematologic Malignancies Industry Research Report 2020, Forecast to 2025

September 2020 | 107 pages | ID: GB0108220F98EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Hematologic Malignancies market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Hematologic Malignancies is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Hematologic Malignancies industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Hematologic Malignancies by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Hematologic Malignancies market are discussed.

The market is segmented by types:

• Leukemia
• Lymphoma
• Multiple Myeloma
• Others

It can be also divided by applications:

• Chemotherapy
• Radiotherapy
• Immunotherapy
• Stem Cell Transplantation
• Others

And this report covers the historical situation, present status and the future prospects of the global Hematologic Malignancies market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Pfizer, Inc.
• Celgene Corporation
• Bristol-Myers Squibb Company
• F. Hoffmann-LA Roche ltd
• GlaxoSmithKline PLC
• Sanofi-Aventis
• Takeda Pharmaceutical Company limited
• Novartis AG
• AbbVie, Inc.
• Johnson & Johnson Services, Inc.

Report Includes:

• xx data tables and xx additional tables
• An overview of global Hematologic Malignancies market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Hematologic Malignancies market
• Profiles of major players in the industry, including Pfizer, Inc., Celgene Corporation, Bristol-Myers Squibb Company, F. Hoffmann-LA Roche ltd, GlaxoSmithKline PLC.....

Research Objectives

• To study and analyze the global Hematologic Malignancies consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Hematologic Malignancies market by identifying its various subsegments.
• Focuses on the key global Hematologic Malignancies manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Hematologic Malignancies with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Hematologic Malignancies submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Hematologic Malignancies Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Hematologic Malignancies Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 HEMATOLOGIC MALIGNANCIES INDUSTRY OVERVIEW

2.1 Global Hematologic Malignancies Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Hematologic Malignancies Global Import Market Analysis
  2.1.2 Hematologic Malignancies Global Export Market Analysis
  2.1.3 Hematologic Malignancies Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Leukemia
  2.2.2 Lymphoma
  2.2.3 Multiple Myeloma
  2.2.4 Others
2.3 Market Analysis by Application
  2.3.1 Chemotherapy
  2.3.2 Radiotherapy
  2.3.3 Immunotherapy
  2.3.4 Stem Cell Transplantation
  2.3.5 Others
2.4 Global Hematologic Malignancies Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Hematologic Malignancies Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Hematologic Malignancies Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Hematologic Malignancies Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Hematologic Malignancies Manufacturer Market Share
  2.4.5 Top 10 Hematologic Malignancies Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Hematologic Malignancies Market
  2.4.7 Key Manufacturers Hematologic Malignancies Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Hematologic Malignancies Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Hematologic Malignancies Industry Impact
  2.7.1 How the Covid-19 is Affecting the Hematologic Malignancies Industry
  2.7.2 Hematologic Malignancies Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Hematologic Malignancies Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Hematologic Malignancies Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Hematologic Malignancies Sales Market Share by Region
4.2 Global Hematologic Malignancies Revenue Market Share by Region (2015-2019)
4.3 Global Hematologic Malignancies Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Hematologic Malignancies Market Size Detail
  4.4.1 North America Hematologic Malignancies Sales Growth Rate (2015-2020)
  4.4.2 North America Hematologic Malignancies Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Hematologic Malignancies Market Size Detail
  4.5.1 Europe Hematologic Malignancies Sales Growth Rate (2015-2020)
  4.5.2 Europe Hematologic Malignancies Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Hematologic Malignancies Market Size Detail
  4.6.1 Japan Hematologic Malignancies Sales Growth Rate (2015-2020)
  4.6.2 Japan Hematologic Malignancies Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Hematologic Malignancies Market Size Detail
  4.7.1 China Hematologic Malignancies Sales Growth Rate (2015-2020)
  4.7.2 China Hematologic Malignancies Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SEGMENT BY TYPE

5.1 Global Hematologic Malignancies Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Hematologic Malignancies Sales and Market Share by Type (2015-2020)
  5.1.2 Global Hematologic Malignancies Revenue and Market Share by Type (2015-2020)
5.2 Leukemia Sales Growth Rate and Price
  5.2.1 Global Leukemia Sales Growth Rate (2015-2020)
  5.2.2 Global Leukemia Price (2015-2020)
5.3 Lymphoma Sales Growth Rate and Price
  5.3.1 Global Lymphoma Sales Growth Rate (2015-2020)
  5.3.2 Global Lymphoma Price (2015-2020)
5.4 Multiple Myeloma Sales Growth Rate and Price
  5.4.1 Global Multiple Myeloma Sales Growth Rate (2015-2020)
  5.4.2 Global Multiple Myeloma Price (2015-2020)
5.5 Others Sales Growth Rate and Price
  5.5.1 Global Others Sales Growth Rate (2015-2020)
  5.5.2 Global Others Price (2015-2020)

6 GLOBAL HEMATOLOGIC MALIGNANCIES MARKET SEGMENT BY APPLICATION

6.1 Global Hematologic MalignanciesSales Market Share by Application (2015-2020)
6.2 Chemotherapy Sales Growth Rate (2015-2020)
6.3 Radiotherapy Sales Growth Rate (2015-2020)
6.4 Immunotherapy Sales Growth Rate (2015-2020)
6.5 Stem Cell Transplantation Sales Growth Rate (2015-2020)
6.6 Others Sales Growth Rate (2015-2020)

7 GLOBAL HEMATOLOGIC MALIGNANCIES MARKET FORECAST

7.1 Global Hematologic Malignancies Sales, Revenue Forecast
  7.1.1 Global Hematologic Malignancies Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Hematologic Malignancies Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Hematologic Malignancies Price and Trend Forecast (2020-2025)
7.2 Global Hematologic Malignancies Sales Forecast by Region (2020-2025)
  7.2.1 North America Hematologic Malignancies Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Hematologic Malignancies Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Hematologic Malignancies Production, Revenue Forecast (2020-2025)
  7.2.4 China Hematologic Malignancies Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF HEMATOLOGIC MALIGNANCIES INDUSTRY KEY MANUFACTURERS

8.1 Pfizer, Inc.
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Pfizer, Inc. Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Pfizer, Inc. News
8.2 Celgene Corporation
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Celgene Corporation Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Celgene Corporation News
8.3 Bristol-Myers Squibb Company
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Bristol-Myers Squibb Company Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Bristol-Myers Squibb Company News
8.4 F. Hoffmann-LA Roche ltd
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 F. Hoffmann-LA Roche ltd Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 F. Hoffmann-LA Roche ltd News
8.5 GlaxoSmithKline PLC
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 GlaxoSmithKline PLC Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 GlaxoSmithKline PLC News
8.6 Sanofi-Aventis
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Sanofi-Aventis Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Sanofi-Aventis News
8.7 Takeda Pharmaceutical Company limited
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Takeda Pharmaceutical Company limited Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Takeda Pharmaceutical Company limited News
8.8 Novartis AG
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Novartis AG Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Novartis AG News
8.9 AbbVie, Inc.
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 AbbVie, Inc. Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 AbbVie, Inc. News
8.10 Johnson & Johnson Services, Inc.
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 Johnson & Johnson Services, Inc. Hematologic Malignancies Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 Johnson & Johnson Services, Inc. News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hematologic Malignancies Picture
Figure Research Programs/Design for This Report
Figure Global Hematologic Malignancies Market by Regions (2019)
Table Global Market Hematologic Malignancies Comparison by Regions (M USD) 2019-2025
Table Global Hematologic Malignancies Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Hematologic Malignancies by Type in 2019
Figure Leukemia Picture
Figure Lymphoma Picture
Figure Multiple Myeloma Picture
Figure Others Picture
Table Global Hematologic Malignancies Sales by Application (2019-2025)
Figure Global Hematologic Malignancies Sales Market Share by Application in 2019
Figure Chemotherapy Picture
Figure Radiotherapy Picture
Figure Immunotherapy Picture
Figure Stem Cell Transplantation Picture
Figure Others Picture
Table Global Hematologic Malignancies Sales by Manufacturer (2018-2020)
Figure Global Hematologic Malignancies Sales Market Share by Manufacturer in 2019
Table Global Hematologic Malignancies Revenue by Manufacturer (2018-2020)
Figure Global Hematologic Malignancies Revenue Market Share by Manufacturer in 2019
Table Global Hematologic Malignancies Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Hematologic Malignancies Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Hematologic Malignancies Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Hematologic Malignancies Market
Table Key Manufacturers Hematologic Malignancies Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hematologic Malignancies
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Hematologic Malignancies Sales (K Units) by Region (2015-2020)
Table Global Hematologic Malignancies Sales Market Share by Region (2015-2019)
Figure Global Hematologic Malignancies Sales Market Share by Region (2015-2019)
Figure Global Hematologic Malignancies Sales Market Share by Region in 2018
Table Global Hematologic Malignancies Revenue (Million US$) by Region (2015-2020)
Table Global Hematologic Malignancies Revenue Market Share by Region (2015-2020)
Figure Global Hematologic Malignancies Revenue Market Share by Region (2015-2020)
Figure Global Hematologic Malignancies Revenue Market Share by Region in 2019
Table Global Hematologic Malignancies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Hematologic Malignancies Sales (K Units) Growth Rate (2015-2020)
Table North America Hematologic Malignancies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Hematologic Malignancies Sales (K Units) Growth Rate (2015-2020)
Table Europe Hematologic Malignancies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Hematologic Malignancies Sales (K Units) Growth Rate (2015-2020)
Table Japan Hematologic Malignancies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Hematologic Malignancies Sales (K Units) Growth Rate (2015-2020)
Table China Hematologic Malignancies Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Hematologic Malignancies Sales by Type (2015-2020)
Table Global Hematologic Malignancies Sales Market Share by Type (2015-2020)
Figure Global Hematologic Malignancies Sales Market Share by Type in 2019
Table Global Hematologic Malignancies Revenue by Type (2015-2020)
Table Global Hematologic Malignancies Revenue Market Share by Type (2015-2020)
Figure Global Hematologic Malignancies Revenue Market Share by Type in 2019
Figure Global Leukemia Sales Growth Rate (2015-2020)
Figure Global Leukemia Price (2015-2020)
Figure Global Lymphoma Sales Growth Rate (2015-2020)
Figure Global Lymphoma Price (2015-2020)
Figure Global Multiple Myeloma Sales Growth Rate (2015-2020)
Figure Global Multiple Myeloma Price (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Hematologic Malignancies Sales by Application (2015-2020)
Table Global Hematologic Malignancies Sales Market Share by Application (2015-2020)
Figure Global Hematologic Malignancies Sales Market Share by Application in 2019
Figure Global Chemotherapy Sales Growth Rate (2015-2020)
Figure Global Radiotherapy Sales Growth Rate (2015-2020)
Figure Global Immunotherapy Sales Growth Rate (2015-2020)
Figure Global Stem Cell Transplantation Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Hematologic Malignancies Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Hematologic Malignancies Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Hematologic Malignancies Price and Trend Forecast (2020-2025)
Table Global Hematologic Malignancies Sales (K Units) Forecast by Region (2020-2025)
Figure Global Hematologic Malignancies Production Market Share Forecast by Region (2020-2025)
Figure North America Hematologic Malignancies Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Hematologic Malignancies Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Hematologic Malignancies Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Hematologic Malignancies Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Hematologic Malignancies Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Hematologic Malignancies Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Hematologic Malignancies Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Hematologic Malignancies Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Pfizer, Inc. Company Profile
Figure Hematologic Malignancies Product Picture and Specifications of Pfizer, Inc.
Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pfizer, Inc. Hematologic Malignancies Market Share (2018-2020)
Table Pfizer, Inc. Main Business
Table Pfizer, Inc. Recent Development
Table Celgene Corporation Company Profile
Figure Hematologic Malignancies Product Picture and Specifications of Celgene Corporation
Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Celgene Corporation Hematologic Malignancies Market Share (2018-2020)
Table Celgene Corporation Main Business
Table Celgene Corporation Recent Development
Table Bristol-Myers Squibb Company Company Profile
Figure Hematologic Malignancies Product Picture and Specifications of Bristol-Myers Squibb Company
Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bristol-Myers Squibb Company Hematologic Malignancies Market Share (2018-2020)
Table Bristol-Myers Squibb Company Main Business
Table Bristol-Myers Squibb Company Recent Development
Table F. Hoffmann-LA Roche ltd Company Profile
Figure Hematologic Malignancies Product Picture and Specifications of F. Hoffmann-LA Roche ltd
Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020
Figure F. Hoffmann-LA Roche ltd Hematologic Malignancies Market Share (2018-2020)
Table F. Hoffmann-LA Roche ltd Main Business
Table F. Hoffmann-LA Roche ltd Recent Development
Table GlaxoSmithKline PLC Company Profile
Figure Hematologic Malignancies Product Picture and Specifications of GlaxoSmithKline PLC
Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020
Figure GlaxoSmithKline PLC Hematologic Malignancies Market Share (2018-2020)
Table GlaxoSmithKline PLC Main Business
Table GlaxoSmithKline PLC Recent Development
Table Sanofi-Aventis Company Profile
Figure Hematologic Malignancies Product Picture and Specifications of Sanofi-Aventis
Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sanofi-Aventis Hematologic Malignancies Market Share (2018-2020)
Table Sanofi-Aventis Main Business
Table Sanofi-Aventis Recent Development
Table Takeda Pharmaceutical Company limited Company Profile
Figure Hematologic Malignancies Product Picture and Specifications of Takeda Pharmaceutical Company limited
Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Takeda Pharmaceutical Company limited Hematologic Malignancies Market Share (2018-2020)
Table Takeda Pharmaceutical Company limited Main Business
Table Takeda Pharmaceutical Company limited Recent Development
Table Novartis AG Company Profile
Figure Hematologic Malignancies Product Picture and Specifications of Novartis AG
Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis AG Hematologic Malignancies Market Share (2018-2020)
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table AbbVie, Inc. Company Profile
Figure Hematologic Malignancies Product Picture and Specifications of AbbVie, Inc.
Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020
Figure AbbVie, Inc. Hematologic Malignancies Market Share (2018-2020)
Table AbbVie, Inc. Main Business
Table AbbVie, Inc. Recent Development
Table Johnson & Johnson Services, Inc. Company Profile
Figure Hematologic Malignancies Product Picture and Specifications of Johnson & Johnson Services, Inc.
Table Hematologic Malignancies Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson Services, Inc. Hematologic Malignancies Market Share (2018-2020)
Table Johnson & Johnson Services, Inc. Main Business
Table Johnson & Johnson Services, Inc. Recent Development
Table of Appendix